37756 Federal Register / Vol. 86, No. 134 / Friday, July 16, 2021 / Notices 

property was no longer available for 

long-term leasing. CDC attempted to 

purchase the underlying property on 

which LLEM is located, but NIOSH 

vacated the LLEM after market-based 

purchase offers were rejected by the 

property owners. 

In 2013, CDC completed a Project 

Development Study to outline a design 

solution to replace the LLEM. The study 

presented the facility and site 

requirements and design concepts for 

the replacement facilities. In 2016, to 

identify potentially available locations 

that could accommodate the space 

requirements defined in the 2013 study, 

GSA issued (on behalf of CDC) two 

separate Requests for Expressions of 

Interest (REOI) for a site, developed or 

undeveloped, that could be used for the 

new underground safety research 

facility. The first REOI, advertised in 

June 2016, contained a limited 

delineated area within a 200-mile radius 

of the LLEM. The REOI set forth criteria 

that would be used to evaluate the 

suitability of the submitted sites. One 

expression of interest that had the 

potential to meet the minimum criteria 

was received. After further evaluation, 

however, the site was found to be nonviable. 

The second REOI was issued in 

October 2016 and expanded the 

delineated area to the entire contiguous 

United States. Three expressions of 

interest were received for sites in 

Kentucky, Missouri, and West Virginia. 

The Kentucky site did not meet the 

minimum criteria, and the Missouri site 

expression of interest did not contain all 

necessary information to evaluate. The 

offeror of the Missouri site did not 

respond to subsequent GSA inquiries. 

The potential site in West Virginia 

met the minimum criteria and was 

determined to be a viable site. The site 

is located near Mace, West Virginia, and 

straddles the Randolph and Pocahontas 

County lines. 

In accordance with NEPA, as 

implemented by the CEQ regulations (40 

CFR parts 1500–1508), with GSA as a 

cooperating agency, CDC prepared a 

Draft EIS for the proposed acquisition of 

the Site and construction of a new 

underground safety research facility on 

the Site. Under NEPA, federal agencies 

are required to evaluate the 

environmental effects of their proposed 

actions and a range of reasonable 

alternatives to the proposed action 

before making a decision. On February 

14, 2019, in accordance with NEPA, 

CDC published a Notice of Availability 

announcing that a Draft EIS for the 

proposed acquisition and development 

had been prepared. The Draft EIS 

evaluated two alternatives: The 

Proposed Action Alternative 

(acquisition of the Site and construction 

of a new underground safety research 

facility) and the No Action Alternative. 

No other alternatives were considered 

because only one qualifying site was 

identified through the site selection 

process discussed above. 

Publication of the Draft EIS notice 

initiated a 51-day review period, which 

ended on April 5, 2019. During this 

period, CDC received comments from 

government agencies, a Native 

American tribe, and the public. These 

comments pertained to the proposed 

action in general, including the purpose 

and need; water quality/groundwater 

impacts; traffic impacts; tourism 

impacts; noise and vibration impacts; 

viewshed impacts; and wildlife impacts. 

All comments were considered when 

preparing the Final EIS and responses to 

the comments are provided in the Final 

EIS. The Final EIS identifies the 

Proposed Action Alternative as CDC’s 

Preferred Alternative. 

CDC will make a decision on whether 

to proceed with the Proposed Action on 

or after August 16, 2021. At that time, 

CDC will issue a Record of Decision 

documenting and explaining its 

decision based on the Final EIS. 

Dated: July 13, 2021. 

Sandra Cashman, 

Executive Secretary, Centers for Disease 

Control and Prevention. 

[FR Doc. 2021–15139 Filed 7–15–21; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[Document Identifier: CMS–10768] 

Agency Information Collection 

Activities: Proposed Collection; 

Comment Request 

AGENCY: Centers for Medicare & 

Medicaid Services, Health and Human 

Services (HHS). 

ACTION: Notice. 

SUMMARY: The Centers for Medicare & 

Medicaid Services (CMS) is announcing 

an opportunity for the public to 

comment on CMS’ intention to collect 

information from the public. Under the 

Paperwork Reduction Act of 1995 (the 

PRA), federal agencies are required to 

publish notice in the Federal Register 

concerning each proposed collection of 

information (including each proposed 

extension or reinstatement of an existing 

collection of information) and to allow 

60 days for public comment on the 

proposed action. Interested persons are 

invited to send comments regarding our 

burden estimates or any other aspect of 

this collection of information, including 

the necessity and utility of the proposed 

information collection for the proper 

performance of the agency’s functions, 

the accuracy of the estimated burden, 

ways to enhance the quality, utility, and 

clarity of the information to be 

collected, and the use of automated 

collection techniques or other forms of 

information technology to minimize the 

information collection burden. 

DATES: Comments must be received by 

September 14, 2021. 

ADDRESSES: When commenting, please 

reference the document identifier or 

OMB control number. To be assured 

consideration, comments and 

recommendations must be submitted in 

any one of the following ways: 

1. Electronically. You may send your 

comments electronically to http://

www.regulations.gov. Follow the 

instructions for ‘‘Comment or 

Submission’’ or ‘‘More Search Options’’ 

to find the information collection 

document(s) that are accepting 

comments. 

2. By regular mail. You may mail 

written comments to the following 

address: CMS, Office of Strategic 

Operations and Regulatory Affairs, 

Division of Regulations Development, 

Attention: Document Identifier/OMB 

Control Number: ll, Room C4–26–05, 

7500 Security Boulevard, Baltimore, 

Maryland 21244–1850. 

To obtain copies of a supporting 

statement and any related forms for the 

proposed collection(s) summarized in 

this notice, you may make your request 

using one of following: 

1. Access CMS’ website address at 

website address at https://www.cms.gov/ 

Regulations-and-Guidance/Legislation/ 

PaperworkReductionActof1995/PRAListing.html. 

FOR FURTHER INFORMATION CONTACT: 

William N. Parham at (410) 786–4669. 

SUPPLEMENTARY INFORMATION: 

Contents 

This notice sets out a summary of the 

use and burden associated with the 

following information collections. More 

detailed information can be found in 

each collection’s supporting statement 

and associated materials (see 

ADDRESSES). 

CMS–10768—The ESRD Network Peer 

Mentoring Program 

Under the PRA (44 U.S.C. 3501– 

3520), federal agencies must obtain 

approval from the Office of Management 

and Budget (OMB) for each collection of 


jbell on DSKJLSW7X2PROD with NOTICES
Federal Register / Vol. 86, No. 134 / Friday, July 16, 2021 / Notices 37757 

information they conduct or sponsor. 

The term ‘‘collection of information’’ is 

defined in 44 U.S.C. 3502(3) and 5 CFR 

1320.3(c) and includes agency requests 

or requirements that members of the 

public submit reports, keep records, or 

provide information to a third party. 

Section 3506(c)(2)(A) of the PRA 

requires federal agencies to publish a 

60-day notice in the Federal Register 

concerning each proposed collection of 

information, including each proposed 

extension or reinstatement of an existing 

collection of information, before 

submitting the collection to OMB for 

approval. To comply with this 

requirement, CMS is publishing this 

notice. 

Information Collection 

1. Type of Information Collection 

Request: New collection (Request for a 

new OMB control number); Title of 

Information Collection: The ESRD 

Network Peer Mentoring Program; Use: 

The End Stage Renal Disease (ESRD) 

Network Peer Mentoring Program is a 

voluntary program designed to provide 

patient peer support to people with 

kidney disease. In part, the peer support 

is beneficial because patients can give 

each other something most practitioners 

do not have: Lived experience with 

kidney disease. The support and 

perspective of someone who has ‘‘been 

there’’ can help people better cope with 

their circumstances. 

The ESRD Network Peer Mentoring 

Program is a partnership between 

dialysis facilities, ESRD Networks, and 

patient peer mentors and mentees that 

wish to engage in the program. The peer 

mentoring program is organized and 

published with educational 

opportunities for peer mentors and 

mentees, provides resources, and 

includes a complementary toolkit for 

ESRD Networks and dialysis facilities to 

promote and operationalize the 

program. 

Program applicants are people with 

ESRD who: (1) Are adults over the age 

of 18; have been receiving in-center or 

home dialysis or have been transplanted 

for at least six months; actively engage 

in the care plan; consistently 

demonstrate leadership qualities at 

facility Quality Assurance & 

Performance Improvement (QAPI) 

meetings, Lobby Days, and other facility 

activities; and wish to be a peer mentor; 

or (2) are over 18 years of age; are newly 

diagnosed patients but have been on incenter dialysis for at least six months; 

are looking for peer support to help 

them transition to their new reality; and 

are known as a peer mentee. 

To participate in the ESRD Network 

Peer Mentoring Program, peer mentors 

and mentees will complete an online 

application form stored in Confluence. 

The application serves to validate the 

peer mentor or peer mentee interest in 

the ESRD Network Peer Mentoring 

Program. Information collection is 

important to the process of pairing peer 

mentors and mentees with similarly 

lived experience and interests with their 

kidney disease. In addition, the 

application collects information about 

the peers’ interest in kidney disease, 

treatment modality, age range, preferred 

gender recognition, and attitudes toward 

their kidney disease diagnosis. It also 

supports aligning hobbies, and genders 

to support best matched peers with each 

other. Form Number: CMS–10768 (OMB 

control number: 0938–NEW); 

Frequency: Once; Affected Public: 

Individuals and Households; Number of 

Respondents: 75; Total Annual 

Responses: 75; Total Annual Hours: 19. 

(For policy questions regarding this 

collection, contact Lisa Rees at 816– 

426–6353.) 

Dated: July 12, 2021. 

William N. Parham, III, 

Director, Paperwork Reduction Staff, Office 

of Strategic Operations and Regulatory 

Affairs. 

[FR Doc. 2021–15099 Filed 7–15–21; 8:45 am] 

BILLING CODE 4120–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Best Practices for Advancing Cultural 

Competency, Language Access and 

Sensitivity Toward Asian Americans 

and Pacific Islanders 

AGENCY: Office of Minority Health, 

Department of Health and Human 

Services (HHS). 

ACTION: Request for information. 

SUMMARY: The U.S. Department of 

Health and Human Services (HHS) 

Office of Minority Health (OMH) seeks 

input from Asian American and Pacific 

Islander (AAPI) communities and AAPIserving organizations to inform the 

development of guidance describing 

best practices for advancing cultural 

competency, language access, and 

sensitivity toward Asian Americans and 

Pacific Islanders in the context of the 

Federal Government’s COVID–19 

response. This is NOT a solicitation for 

proposals or proposal abstracts. 

Please note: This request is for 

information (RFI) and is for planning 

purposes only. It is not a notice for a 

proposal and does not commit the 

federal government to issue a 

solicitation, make an award, or pay any 

costs associated with responding to this 

announcement. All submitted 

information shall remain with the 

federal government and will not be 

returned. All responses will become 

part of the public record and will not be 

held confidential. The federal 

government reserves the right to use 

information provided by respondents 

for purposes deemed necessary and 

legally appropriate. Respondents are 

advised that the federal government is 

under no obligation to acknowledge 

receipt of the information received or 

provide feedback to respondents with 

respect to any information submitted. 

Responses will not be accepted after the 

due date. After a review of the responses 

received, a notice of funding 

opportunity or pre-solicitation synopsis 

and solicitation may be published. 

DATES: To be assured consideration in 

the development of best practices 

guidance, written comments must be 

submitted and received at the address 

provided below, no later than 11:59 

p.m. on August 17, 2021. 

ADDRESSES: OMH invites the 

submission of the requested information 

through one of the following methods: 

• Preferred method: Submit 

information through the Federal 

eRulemaking Portal at http://

www.regulations.gov. Follow the online 

instructions for submissions. 

• Email: Send comments to 

minorityhealth@hhs.gov with the 

subject line ‘‘OMH RFI: AAPI Best 

Practices.’’ 

Submissions received after the 

deadline will not be reviewed. Respond 

concisely and in plain language. You 

may use any structure or layout that 

presents your information well. You 

may respond to some or all of our 

questions, and you can suggest other 

factors or relevant questions. You may 

also include links to online material or 

interactive presentations. Clearly mark 

any proprietary information and place it 

in its own section or file. Your response 

will become government property, and 

we may publish some of its nonproprietary content. 

FOR FURTHER INFORMATION CONTACT: 

Juliet Bui, 1101 Wootton Parkway, Suite 

100, Rockville, MD, 20852, (240) 453– 

6166, Juliet.Bui@hhs.gov. 

SUPPLEMENTARY INFORMATION: 

I. Background Information 

On January 26, 2021, President Biden 

issued a Memorandum Condemning and 

Combating Racism, Xenophobia, and 

Intolerance against Asian Americans 

and Pacific Islanders in the United 

States. The memorandum directed the 

HHS Secretary, in coordination with the 

COVID–19 Health Equity Task Force, to 


jbell on DSKJLSW7X2PROD with NOTICES